CRL - Charles River Laboratories International, Inc.

NYSE - NYSE Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 9.79B
Enterprise value 12.65B
Trailing P/E 20.17
Forward P/E 18.28
PEG ratio (5-yr expected) 1.26
Price/sales (ttm)2.47
Price/book (mrq)3.29
Enterprise value/revenue 3.09
Enterprise value/EBITDA 12.25

Trading information

Stock price history

Beta (5Y monthly) 1.34
52-week change 3-17.07%
S&P500 52-week change 31.77%
52-week high 3262.00
52-week low 3181.22
50-day moving average 3195.91
200-day moving average 3214.39

Share statistics

Avg vol (3-month) 3561.4k
Avg vol (10-day) 3590.22k
Shares outstanding 551.18M
Implied shares outstanding 6N/A
Float 850.58M
% held by insiders 10.98%
% held by institutions 199.00%
Shares short (14 May 2023) 41.34M
Short ratio (14 May 2023) 42.22
Short % of float (14 May 2023) 43.00%
Short % of shares outstanding (14 May 2023) 42.62%
Shares short (prior month 13 Apr 2023) 41.38M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)31 Mar 2023


Profit margin 12.13%
Operating margin (ttm)16.41%

Management effectiveness

Return on assets (ttm)5.68%
Return on equity (ttm)17.21%

Income statement

Revenue (ttm)4.09B
Revenue per share (ttm)80.34
Quarterly revenue growth (yoy)12.60%
Gross profit (ttm)1.46B
EBITDA 977.24M
Net income avi to common (ttm)496.34M
Diluted EPS (ttm)9.47
Quarterly earnings growth (yoy)10.90%

Balance sheet

Total cash (mrq)201.59M
Total cash per share (mrq)3.94
Total debt (mrq)3.17B
Total debt/equity (mrq)100.38
Current ratio (mrq)1.48
Book value per share (mrq)60.74

Cash flow statement

Operating cash flow (ttm)626.39M
Levered free cash flow (ttm)258.57M